Sage Journals: Discover world-class research

Abstract

Objective:

To evaluate the diagnostic accuracy of the BACs-on-Beads (BoBs) assay for the rapid diagnosis of common aneuploidies and microdeletion syndromes.

Methods:

BACs-on-Beads and chromosomal karyotyping were used for detecting 3647 cases of amniotic fluid samples with indications for prenatal diagnosis, which were collected from January 2015 to June 2017 in Xijing Hospital. Fluorescence in situ hybridization (FISH) or chromosomal microarray analysis (CMA) provided further validation.

Results:

The overall abnormality detection rate (BoBs combined with karyotyping) was 7.73% (282/3647). A total of 209 chromosomal aneuploidies, 10 mosaic cases, 11 microdeletion/microduplication syndromes, and 52 structural abnormalities were observed. Both assays were concordant for trisomy 21 (4.22%, 154/3647), trisomy 18 (0.69%, 25/3647), trisomy 13 (0.05%, 2/3647), and sex chromosome aneuploidies (0.77%, 28/3647). Meanwhile, DiGeorge syndrome (0.05%, 2/3647), 22q11.2 microduplication (0.08%, 3/3647), Smith-Magenis syndrome (0.03%, 1/3647), 17p11.2 microduplication (0.03%, 1/3647), Wolf-Hirschhorn syndrome (0.03%, 1/3647), Williams-Beuren syndrome (0.03%, 1/3647), Cri du Chat syndrome (0.03%, 1/3647), and Miller-Dieker syndrome (0.03%, 1/3647) were identified by BoBs assay, thus giving the incidence of the detection of these syndromes of 0.30% (11/3647).

Conclusion:

BACs-on-Beads assay is a reliable test for rapid detection of common aneuploidies and microdeletion syndromes, combining with karyotyping, FISH, and CMA, to improve the efficiency and accuracy of prenatal diagnosis to alleviate maternal emotional anxiety.

Keywords

BoBs assay chromosomal karyotyping prenatal diagnosis

Get full access to this article

View all access options for this article.

References

Rosano

Botto

Botting

Mastroiacovo

. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J Epidemiol Community Health. 2000;54(9):660–666.

Caramins

Saville

Shakeshaft

. A comparison of molecular and cytogenetic techniques for the diagnosis of pregnancy loss. Genet Med. 2011;13(1):46–51.

Gross

Bajaj

Garry

. Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes. Prenat Diagn. 2011;31(3):259–266.

Choy

Chen

Sun

Kwok

Leung

. BACs-on-beads: a new robust and rapid detection method for prenatal diagnosis. Expert Rev Mol Diagn. 2014;14(3):273–280.

Vialard

Simoni

Aboura

. Prenatal BACs-on-Beads^TM: a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis. Prenat Diagn. 2011;31(5):500–508.

Choy

Kwok

Cheng

. Diagnostic accuracy of the BACs-on-Beads^TM assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series. BJOG. 2014;121(10):1245–1252.

Vialard

Simoni

Gomes

. Prenatal BACs-on-Beads^TM: the prospective experience of five prenatal diagnosis laboratories. Prenat Diagn. 2012;32(4):329–335.

Grati

Molina Gomes

Ferreira

. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn. 2015;35(8):801–809.

Cheng

Wong

. The detection of mosaicism by prenatal BoBs^TM . Prenat Diagn. 2013;33(1):42–49.

10.

García-Herrero

Campos-Galindo

Martínez-Conejero

. BACs-on-beads technology: a reliable test for rapid detection of aneuploidies and microdeletions in prenatal diagnosis. Biomed Res Int. 2014;2014(13):590298.

11.

Shaffer

Coppinger

Morton

. The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes. Prenat Diagn. 2011;31(8):778–787.

12.

Ensenauer

Adeyinka

Flynn

. Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet. 2003;73(5):1027–1040.

13.

Portnoï

. Microduplication 22q11.2: a new chromosomal syndrome. Eur J Med Genet. 2009;52(2-3):88–93.

14.

Weisfeld-Adams

Edelmann

Gadi

Mehta

. Phenotypic heterogeneity in a family with a small atypical microduplication of chromosome 22q11.2 involving TBX1. Eur J Med Genet. 2012;55(12):732–736.

15.

Dugoff

Norton

Kuller

. The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016;215(4):B2–B9.

16.

Xia

Yang

Huang

Zhang

. Clinical application of chromosomal microarray analysis for the prenatal diagnosis of chromosomal abnormalities and copy number variations in fetuses with congenital heart disease. Prenat Diagn. 2018;38(6):406–413.

17.

Fan

Wang

. Chromosomal microarray analysis in developmental delay and intellectual disability with comorbid conditions. BMC Med Genomics. 2018;11(1):49.

18.

Lee

Hwang

Kim

. Chromosomal microarray with clinical diagnostic utility in children with developmental delay or intellectual disability. Ann Lab Med. 2018;38(5):473–480.

19.

Wang

Tao

. The clinical use of chromosomal microarray analysis in detection of fetal chromosomal rearrangements: a study from China Mainland. Eur J Obstet Gynecol Reprod Biol. 2017;212:44–50.

20.

Malan

Lapierre

Egloff

. A French approach to test fetuses with ultrasound abnormalities using a customized microarray as first-tier genetic test. Cytogenet Genome Res. 2015;147(2-3):103–110.

21.

Wapner

Martin

Levy

. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184.

22.

Evans

Bennett

Wapner

. The price of abandoning diagnostic testing for cell-free fetal DNA screening. Prenat Diagn. 2018;38(4):243–245.

23.

Hui

Norton

. What is the real “price” of more prenatal screening and fewer diagnostic procedures? Costs and trade-offs in the genomic era. Prenat Diagn. 2018;38(4):246–249.

24.

Harper

Sutton

Longman

Odibo

. An economic analysis of prenatal cytogenetic technologies for sonographically detected fetal anomalies. Am J Med Genet A. 2014;164A(5):1192–1197.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.15 MB

Prenatal Diagnosis of BACs-on-Beads Assay in 3647 Cases of Amniotic Fluid Cells